Congressional Insider Trading: Notable Cases of Politicians Trading on Privileged Info

Members of Congress have access to information that can move markets — advance knowledge of legislation, regulatory decisions, classified briefings, and private meetings with industry leaders. Whether and how lawmakers trade on that information has been a source of public controversy for decades. Despite the passage of the STOCK Act in 2012, enforcement remains inconsistent and several high-profile cases have raised questions about whether members of Congress play by the same rules as everyone else when it comes to insider trading law.

Chris Collins and Innate Immunotherapeutics: The White House Phone Call

U.S. Representative Chris Collins (R-NY) became the first sitting member of Congress convicted of insider trading when he pleaded guilty in 2019. Collins served on the board of Innate Immunotherapeutics, an Australian biotechnology company developing a treatment for multiple sclerosis.

On June 22, 2017, while attending the annual Congressional Picnic at the White House, Collins received an email from Innate's CEO informing him that the company's drug had failed a critical clinical trial. Within minutes, Collins called his son Cameron Collins from the White House lawn. Cameron sold his Innate shares the next morning — before the negative results were made public — and tipped other family members and associates to do the same.

The trades avoided losses of approximately $768,000. Phone records showed a rapid chain of calls from Collins to his son and then from his son to other tippees, creating a clear trail. Collins was initially defiant, winning re-election in November 2018 even after his indictment. He eventually pleaded guilty to conspiracy to commit securities fraud and making false statements, and was sentenced to 26 months in federal prison. He received a pardon from President Trump in December 2020.

Richard Burr and COVID-19 Stock Sales (2020)

Senator Richard Burr (R-NC), then chairman of the Senate Intelligence Committee, sold between $628,000 and $1.72 million in stocks on February 13, 2020 — just days after receiving classified briefings about the severity of the emerging COVID-19 pandemic. The sales came before the market crash that would wipe out trillions in value over the following weeks.

The timing was particularly problematic because Burr had access to classified intelligence about the pandemic's likely impact while publicly downplaying the threat. In a February 7 op-ed, Burr had written that the United States was "better prepared than ever before" to face emerging threats. Six days later, he liquidated significant stock positions.

The FBI seized Burr's cell phone as part of its investigation. The Department of Justice ultimately closed its investigation in January 2021 without bringing charges, concluding that there was insufficient evidence to prove a criminal case beyond a reasonable doubt. The Senate Ethics Committee also dropped its inquiry. Burr stepped down as Intelligence Committee chairman during the investigation and did not seek re-election.

Kelly Loeffler and COVID-19 Stock Trades (2020)

Senator Kelly Loeffler (R-GA) faced scrutiny for stock sales beginning on January 24, 2020 — the same day the Senate Health Committee, on which she served, received a private briefing about COVID-19 from public health officials. Over the following weeks, Loeffler and her husband (Jeffrey Sprecher, chairman of the New York Stock Exchange) sold millions of dollars in stock holdings while purchasing shares in companies that would benefit from the pandemic, such as a teleworking software company.

Loeffler denied wrongdoing, stating that her trades were managed by third-party advisors without her input. The Department of Justice and the SEC both investigated and closed their inquiries without bringing charges. The Senate Ethics Committee also found no violation. However, the controversy dogged Loeffler through her 2020-2021 Senate campaign, which she ultimately lost.

William Jefferson: $90,000 in the Freezer

While not strictly an insider trading case, Representative William Jefferson (D-LA) committed what may be the most colorful financial crime by a sitting member of Congress. In August 2005, FBI agents searching Jefferson's home found $90,000 in cash wrapped in aluminum foil and hidden in frozen food containers in his freezer.

The cash was part of a bribery scheme in which Jefferson accepted payments in exchange for using his Congressional influence to promote business ventures in West Africa. Jefferson was convicted in 2009 on 11 counts of bribery, racketeering, and money laundering, and was sentenced to 13 years in prison — the longest sentence ever given to a member of Congress for corruption at that time.

While Jefferson's case involved bribery rather than securities trading, it demonstrated the same fundamental problem: elected officials using their public position for private financial gain. The case contributed to the growing public demand for greater transparency and accountability in congressional finances.

The STOCK Act: Closing the Congressional Loophole

For most of American history, it was unclear whether insider trading laws even applied to members of Congress. The Constitution's Speech or Debate Clause provides legislators with certain legal immunities, and some legal scholars argued that lawmakers had no fiduciary duty to the investing public that would trigger insider trading liability.

The Stop Trading on Congressional Knowledge (STOCK) Act, signed into law in April 2012, explicitly confirmed that members of Congress, their staffs, and other federal employees are subject to existing insider trading prohibitions. The law also required:

• Disclosure of securities transactions within 45 days
• Public online posting of financial disclosure reports
• Prohibition on using non-public information obtained through official duties for personal trading

However, the STOCK Act's effectiveness has been questioned. In April 2013 — just one year after the law was signed with great fanfare — Congress quietly passed an amendment that rolled back the online disclosure requirements for congressional staff and senior executive branch officials. The amendment was passed with virtually no debate and signed by the President within days.

Ongoing Enforcement Challenges

Despite the STOCK Act, enforcement of congressional insider trading remains deeply problematic. Several structural issues persist:

• Delayed and incomplete disclosures: Studies have found that many members of Congress routinely file their trading disclosures late, sometimes by months. Penalties for late filing are minimal — typically a $200 fine that is often waived.
• Difficulty proving intent: Prosecutors must prove that a lawmaker traded specifically because of non-public information obtained through official duties. Members can argue that their trades were based on publicly available information, personal financial planning, or advisor recommendations.
• Political complications: The Department of Justice faces inherent challenges in prosecuting sitting members of Congress, given the political sensitivities and constitutional issues involved.
• Self-policing limitations: The Senate and House Ethics Committees, which share jurisdiction over congressional trading, are composed of members who may be reluctant to aggressively police their colleagues.

Various proposals have been introduced to address these issues, including bills that would require members of Congress to place their investments in blind trusts or divest individual stock holdings entirely. As of now, none of these broader reforms have passed.

For investors who track insider trading activity, congressional trading data offers an additional dimension of analysis. When lawmakers with committee oversight of specific industries trade in those sectors, it can raise legitimate questions — even when the trades may be perfectly legal. The same principle that makes Form 4 filings valuable — transparency about what informed people are doing with their money — applies to congressional disclosures as well.